Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesEarnAISquareMore
Update: InnovAge Jumps Pre-Bell After Reporting Profit in Fiscal Q4 as Revenue Surged

Update: InnovAge Jumps Pre-Bell After Reporting Profit in Fiscal Q4 as Revenue Surged

MT newswireMT newswire2026/09/09 09:36
05:36 AM EDT, 09/09/2026 (MT Newswires) -- (Updates with the stock move in the headline and the first paragraph.) InnovAge Holding (INNV) shares were up 13.4% in Wednesday's premarket activity after the company swung to earnings in fiscal Q4 following stronger-than-expected sales growth. The company reported fiscal Q4 net income of $0.06 per diluted share late Tuesday, up from a loss of $0.01 a year earlier. Two analysts surveyed by FactSet expected earnings of $0.09. Revenue in the three months ended June 30 rose to $262 million from $221.4 million a year earlier. Three analysts projected $238.3 million. The company expects fiscal 2027 revenue of $1.05 billion to $1.085 billion. Three analysts project $1.04 billion.
0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

siRNA rising star ADARx (ADRX.US) launches $350 millions IPO, AbbVie subscribes to 4.9% of shares with a maximum investment of $100 millions

ADARx plans to raise $350 millions and list on Nasdaq. AbbVie will invest up to $100 millions to acquire a 4.9% stake, with a median valuation of $1.8 billions.

智通财经2026/09/22 07:21

Roche (RHHBY.US) weight loss injection shows positive mid-term trial results: average weight loss of 15.5% over 48 weeks, blood sugar levels drop by 2.65%.

The experimental weight-loss injection enicepatide simultaneously lowered blood sugar and body weight in overweight or obese patients with type 2 diabetes during a mid-stage clinical trial.

智通财经2026/09/22 07:11

SPAC company Silicon Valley Acquisition II (SVATU.US) applies for US stock IPO, aiming to raise up to 220 millions USD.

The blank-check company (SPAC) Silicon Valley Acquisition II submitted a filing to the U.S. Securities and Exchange Commission (SEC) on Monday, planning to raise up to 220 millions USD through an initial public offering (IPO).

智通财经2026/09/22 07:11